| David Hein, MD | |
|
400 S Santa Fe Ave, Salina, KS 67401 | |
| (785) 452-7163 | |
| (785) 452-6873 |
| Full Name | David Hein |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 8 Years |
| Location | 400 S Santa Fe Ave, Salina, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134583941 | NPI | - | NPPES |
| 201251710A | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 0442075 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Salina Regional Health Center | Salina, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Salina Regional Health Center Inc | 0446168215 | 138 |
News Archive
The Children's Hospital of Philadelphia has joined a new consortium announced today by the National Institutes of Health to advance the treatment of chronic inflammatory diseases called eosinophilic disorders.
Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today announced its financial results for the three months and year ended December 31, 2010.
Epizyme, Inc., a company leading the discovery and development of personalized therapeutics for genetically-defined cancer and rare disease patients, and its collaborators announced the publication in Cancer Cell of breakthrough research in the treatment of MLL-rearranged leukemia (MLL), a genetically-defined subset of acute lymphoblastic leukemia and acute myelogenous leukemia.
BLOCKING a key DNA damage repair enzyme, called APE1, could provide a new way to kill cancer cells containing faulty BRCA genes, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.
Women who were treated with radiation therapy to cure Wilms tumor as a child can go on to have healthy babies so long as their entire pelvis was not irradiated, according to a new study in the April 2004 issue of the International Journal of Radiation Oncology-Biology-Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.
› Verified 1 days ago
| Entity Name | Salina Regional Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619952785 PECOS PAC ID: 0446168215 Enrollment ID: O20040130000800 |
News Archive
The Children's Hospital of Philadelphia has joined a new consortium announced today by the National Institutes of Health to advance the treatment of chronic inflammatory diseases called eosinophilic disorders.
Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today announced its financial results for the three months and year ended December 31, 2010.
Epizyme, Inc., a company leading the discovery and development of personalized therapeutics for genetically-defined cancer and rare disease patients, and its collaborators announced the publication in Cancer Cell of breakthrough research in the treatment of MLL-rearranged leukemia (MLL), a genetically-defined subset of acute lymphoblastic leukemia and acute myelogenous leukemia.
BLOCKING a key DNA damage repair enzyme, called APE1, could provide a new way to kill cancer cells containing faulty BRCA genes, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.
Women who were treated with radiation therapy to cure Wilms tumor as a child can go on to have healthy babies so long as their entire pelvis was not irradiated, according to a new study in the April 2004 issue of the International Journal of Radiation Oncology-Biology-Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.
› Verified 1 days ago
| Entity Name | Lindsborg Community Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023001021 PECOS PAC ID: 3971556580 Enrollment ID: O20050223000687 |
News Archive
The Children's Hospital of Philadelphia has joined a new consortium announced today by the National Institutes of Health to advance the treatment of chronic inflammatory diseases called eosinophilic disorders.
Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today announced its financial results for the three months and year ended December 31, 2010.
Epizyme, Inc., a company leading the discovery and development of personalized therapeutics for genetically-defined cancer and rare disease patients, and its collaborators announced the publication in Cancer Cell of breakthrough research in the treatment of MLL-rearranged leukemia (MLL), a genetically-defined subset of acute lymphoblastic leukemia and acute myelogenous leukemia.
BLOCKING a key DNA damage repair enzyme, called APE1, could provide a new way to kill cancer cells containing faulty BRCA genes, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.
Women who were treated with radiation therapy to cure Wilms tumor as a child can go on to have healthy babies so long as their entire pelvis was not irradiated, according to a new study in the April 2004 issue of the International Journal of Radiation Oncology-Biology-Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Hein, MD 400 S Santa Fe Ave, Salina, KS 67401 Ph: (785) 452-7163 | David Hein, MD 400 S Santa Fe Ave, Salina, KS 67401 Ph: (785) 452-7163 |
News Archive
The Children's Hospital of Philadelphia has joined a new consortium announced today by the National Institutes of Health to advance the treatment of chronic inflammatory diseases called eosinophilic disorders.
Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today announced its financial results for the three months and year ended December 31, 2010.
Epizyme, Inc., a company leading the discovery and development of personalized therapeutics for genetically-defined cancer and rare disease patients, and its collaborators announced the publication in Cancer Cell of breakthrough research in the treatment of MLL-rearranged leukemia (MLL), a genetically-defined subset of acute lymphoblastic leukemia and acute myelogenous leukemia.
BLOCKING a key DNA damage repair enzyme, called APE1, could provide a new way to kill cancer cells containing faulty BRCA genes, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.
Women who were treated with radiation therapy to cure Wilms tumor as a child can go on to have healthy babies so long as their entire pelvis was not irradiated, according to a new study in the April 2004 issue of the International Journal of Radiation Oncology-Biology-Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.
› Verified 1 days ago
Rebecca Louise Weller, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 S Santa Fe Ave, Salina, KS 67401 Phone: 785-452-7163 Fax: 785-452-6873 | |
Dr. David M Dupy, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 S Santa Fe Ave, Salina, KS 67401 Phone: 785-452-7163 Fax: 785-452-6873 | |
Jeremiah S. Ostmeyer, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 S Santa Fe Ave, Emergency Dept, Salina, KS 67401 Phone: 785-452-7163 Fax: 785-452-6873 | |
Dr. Bridget Renee Byquist, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 S Santa Fe Ave, Salina, KS 67401 Phone: 857-452-7163 Fax: 785-452-6873 | |
Zachary Jepson, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 400 S Santa Fe Ave, Salina, KS 67401 Phone: 785-452-7163 Fax: 785-452-6873 | |
Emily Jo Bounds, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 S Santa Fe Ave, Salina, KS 67401 Phone: 785-452-7163 Fax: 785-452-6873 |